These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 17227329

  • 1. Experiences of patients with insulin-treated diabetes in conscript military service.
    Sane T, Rautuoja A, Mäkelä M, Westerberg J, Lehesjoki M.
    Diabet Med; 2007 Jan; 24(1):87-90. PubMed ID: 17227329
    [Abstract] [Full Text] [Related]

  • 2. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.
    Lecomte P, Romon I, Fosse S, Simon D, Fagot-Campagna A.
    Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703
    [Abstract] [Full Text] [Related]

  • 3. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.
    Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, Band MM, Reekie G, Leese GP, DARTS/MEMO Collaboration.
    Diabet Med; 2005 Jun; 22(6):749-55. PubMed ID: 15910627
    [Abstract] [Full Text] [Related]

  • 4. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.
    Khutsoane D, Sharma SK, Almustafa M, Jang HC, Azar ST, Danciulescu R, Shestakova M, Ayad NM, Guler S, Bech OM, PRESENT Study Group.
    Diabetes Obes Metab; 2008 Mar; 10(3):212-22. PubMed ID: 18269636
    [Abstract] [Full Text] [Related]

  • 5. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
    Thomas RM, Aldibbiat A, Griffin W, Cox MA, Leech NJ, Shaw JA.
    Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
    [Abstract] [Full Text] [Related]

  • 6. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
    Dornhorst A, Lüddeke HJ, Sreenan S, Koenen C, Hansen JB, Tsur A, Landstedt-Hallin L.
    Int J Clin Pract; 2007 Mar; 61(3):523-8. PubMed ID: 17313628
    [Abstract] [Full Text] [Related]

  • 8. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K, Dornhorst A, Sreenan S.
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [Abstract] [Full Text] [Related]

  • 9. Flexible intensive insulin therapy in adults with type 1 diabetes and high risk for severe hypoglycemia and diabetic ketoacidosis.
    Sämann A, Mühlhauser I, Bender R, Hunger-Dathe W, Kloos C, Müller UA.
    Diabetes Care; 2006 Oct; 29(10):2196-9. PubMed ID: 17003292
    [Abstract] [Full Text] [Related]

  • 10. Clinical characterisation of severe hypoglycaemia--a prospective population-based study.
    Holstein A, Plaschke A, Egberts EH.
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):364-9. PubMed ID: 14520604
    [Abstract] [Full Text] [Related]

  • 11. Metabolic control with insulin pump therapy: the Waikato experience.
    Reda E, Von Reitzenstein A, Dunn P.
    N Z Med J; 2007 Jan 26; 120(1248):U2401. PubMed ID: 17277817
    [Abstract] [Full Text] [Related]

  • 12. Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations.
    Wentholt IM, Maran A, Masurel N, Heine RJ, Hoekstra JB, DeVries JH.
    Diabet Med; 2007 May 26; 24(5):527-32. PubMed ID: 17381503
    [Abstract] [Full Text] [Related]

  • 13. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.
    Fajardo Montañana C, Hernández Herrero C, Rivas Fernández M.
    Diabet Med; 2008 Aug 26; 25(8):916-23. PubMed ID: 18959604
    [Abstract] [Full Text] [Related]

  • 14. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC, Sutton AJ.
    Diabet Med; 2008 Jul 26; 25(7):765-74. PubMed ID: 18644063
    [Abstract] [Full Text] [Related]

  • 15. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H, Kohlmann T, Landgraf W, Holle R, Pirk O, Scholten T.
    Dtsch Med Wochenschr; 2009 Jun 26; 134(23):1207-13. PubMed ID: 19472091
    [Abstract] [Full Text] [Related]

  • 16. The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study.
    Derijks HJ, Heerdink ER, De Koning FH, Janknegt R, Klungel OH, Egberts AC.
    Pharmacoepidemiol Drug Saf; 2008 Apr 26; 17(4):336-44. PubMed ID: 18302302
    [Abstract] [Full Text] [Related]

  • 17. Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes.
    de Galan BE, Schouwenberg BJ, Tack CJ, Smits P.
    Neth J Med; 2006 Sep 26; 64(8):269-79. PubMed ID: 16990690
    [Abstract] [Full Text] [Related]

  • 18. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B, Muche R, Riegger I, Moritz M, Heinze E, Debatin KM, Wabitsch M, Karges W.
    Clin Ther; 2006 Dec 26; 28(12):2094-101. PubMed ID: 17296465
    [Abstract] [Full Text] [Related]

  • 19. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
    Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y, IMPROVE Study Group Expert Panel.
    Int J Clin Pract; 2009 Mar 26; 63(3):522-31. PubMed ID: 19187170
    [Abstract] [Full Text] [Related]

  • 20. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
    Päivärinta M, Tapanainen P, Veijola R.
    Pediatr Diabetes; 2008 Jun 26; 9(3 Pt 2):83-90. PubMed ID: 18221431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.